Literature DB >> 2845893

Coxsackievirus B-3 selection of virus resistant Buffalo green monkey kidney cells and chromosome analysis of parental and resistant cells.

Y Cao1, K H Walen, D Schnurr.   

Abstract

Following coxsackievirus B-3 (CBV-3) infection and lysis of highly susceptible Buffalo green monkey kidney (BGMK) cells, there was a regrowth of cells. Cultures of regrown cells were established and they continued to release infectious CBV-3 for up to 20 weeks. The parental BGMK cells were susceptible to CBV-3, CBV-4 and poliovirus type 2 induced cytopathic effect (CPE), while the cured cells were resistant to CBV-3 and CBV-4 but not to poliovirus type 2. Attachment of CBV-3 was restricted on cured BGMK cells but not on parental cells. Chromosome analysis showed that the cured cells originated from the BGMK cell line and that they were missing two marker chromosomes present in the parental cells.

Entities:  

Mesh:

Year:  1988        PMID: 2845893     DOI: 10.1007/bf01311002

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  14 in total

1.  Persistent infection of YAC-1 cells by coxsackievirus B3.

Authors:  Y Cao; D P Schnurr
Journal:  J Gen Virol       Date:  1988-01       Impact factor: 3.891

2.  Persistent infection of rat insulinoma cells with Coxsackie B4 virus. Brief report.

Authors:  J A Frank; E V Schmidt; R E Smith; C M Wilfert
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

3.  Persistence of Coxsackie B1 virus in Balb/C mice.

Authors:  E V Bocharov; O V Shalaurova
Journal:  Acta Virol       Date:  1984-07       Impact factor: 1.162

4.  Characteristics of the BGM line of cells from African green monkey kidney. Brief report.

Authors:  A L Barron; C Olshevsky; M M Cohen
Journal:  Arch Gesamte Virusforsch       Date:  1970

5.  Coxsackievirus B3 persistence and myocarditis in NFR nu/nu and +/nu mice.

Authors:  D P Schnurr; N J Schmidt
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

6.  Dermatomyositis, polymyositis, and Coxsackie-B-virus infection.

Authors:  N E Bowles; V Dubowitz; C A Sewry; L C Archard
Journal:  Lancet       Date:  1987-05-02       Impact factor: 79.321

7.  Coxsackievirus B3 persistence and myocarditis in N:NIH(S) II nu/nu and +/nu mice.

Authors:  D P Schnurr; Y Cao; N J Schmidt
Journal:  J Gen Virol       Date:  1984-07       Impact factor: 3.891

8.  Persistent infection of mouse fibroblasts with Coxsackievirus.

Authors:  D P Schnurr; N J Schmidt
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

9.  Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy.

Authors:  N E Bowles; P J Richardson; E G Olsen; L C Archard
Journal:  Lancet       Date:  1986-05-17       Impact factor: 79.321

10.  The mammalian cell-virus relationship. VI. Sustained infection of HeLa cells by Coxsackie B3 virus and effect on superinfection.

Authors:  R L CROWELL; J T SYVERTON
Journal:  J Exp Med       Date:  1961-02-01       Impact factor: 14.307

View more
  4 in total

1.  Spectrum of monoclonal antibodies to coxsackievirus B-3 includes type- and group-specific antibodies.

Authors:  S Yagi; D Schnurr; J Lin
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

2.  Non-cytopathic infection of rhabdomyosarcoma cells by coxsackie B5 virus.

Authors:  E Argo; B Gimenez; P Cash
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

Review 3.  Assessing the Occurrence of Waterborne Viruses in Reuse Systems: Analytical Limits and Needs.

Authors:  Charles P Gerba; Walter Q Betancourt
Journal:  Pathogens       Date:  2019-07-22

Review 4.  Oncolytic viruses in cancer therapy.

Authors:  Markus J V Vähä-Koskela; Jari E Heikkilä; Ari E Hinkkanen
Journal:  Cancer Lett       Date:  2007-03-23       Impact factor: 8.679

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.